142 results on '"N D Heaton"'
Search Results
52. 519 CELLULAR TH1 AND TH2 IMMUNE RESPONSES TO ALCOHOL DEHYDROGENASE WITHIN THE LIVER OF PATIENTS WITH ALCOHOL-RELATED CIRRHOSIS DESPITE ABSTINENCE
53. 57 SECRETORY LEUKOCYTE PROTEASE INHIBITOR (SLPI) IS A PIVOTAL MEDIATOR OF ANTI-INFLAMMATORY RESPONSES IN ACUTE LIVER FAILURE
54. Small bowel flora and bacterial translocation in potential small bowel transplant donors
55. P0377 HEPATOPULMONARY SYNDROME IN CHILDREN: A SINGLE CENTRE EXPERIENCE
56. Current Experience in Liver Transplantation from Cardiac Death Donation at Kingʼs College Hospital
57. Nitric oxide synthase induction and chronic cardiac allograft rejection
58. Liver transplantation for neonatal haemochromatosis
59. PMO-159 Ethnic origin and variation in outcome in patients with hepatocellular carcinoma and hepatitis B infection
60. PTU-012 The impact of comorbidity on post liver transplant survival and resource utilisation in patients transplanted for acute liver failure utilising the Charlson comorbidity index
61. PTU-056 The effect of hepatitis C infection on the utility of alpha-fetoprotein as a surveillance marker for tumour recurrence following liver transplantation for hepatocellular carcinoma
62. PWE-291 MAPK signalling regulates the development of a cholangiocellular phenotype from HCC in post-TACE liver transplants
63. OC-041 IL28B haplotypes and IP-10 predict treatment response for recurrent HCV post transplant
64. 234 THE IMPACT OF COMORBIDITY ON POST LIVER TRANSPLANT SURVIVAL AND RESOURCE UTILIZATION IN PATIENTS TRANSPLANTED FOR ACUTE LIVER FAILURE UTILIZING THE CHARLSON COMORBIDITY INDEX
65. 225 REDUCING RISK FACTORS FOR SKIN CANCER DEVELOPMENT FOLLOWING LIVER TRANSPLANT - THE NEED FOR MORE EFFECTIVE PATIENT EDUCATION AND HEALTH PROMOTION
66. 92 THE HEPATIC INFLAMMATORY MICROENVIRONMENT INDUCES ENDOTOXIN TOLERANT MONOCYTES IN ACETAMINOPHEN-INDUCED LIVER FAILURE
67. 283 MIXED-PHENOTYPE HEPATOCELLULAR CARCINOMA IN LIVER TRANSPLANTS AFTER USE OF TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IS ASSOCIATED WITH ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASE (MAPK) SIGNALLING PATHWAY
68. 1416 PLASMA PHOSHOLIPID PROFILING BY METABONOMICS: HIGHLY ACCURATE OUTCOME PREDICTION IN DECOMPENSATED CIRRHOSIS
69. 175 LOW ACCELERATING DOSE INDIVIDUALISED DURATION TREATMENT REGIMEN FOR RECURENT HCV POST LIVER TRANSPLANTATION
70. Orthotopic liver transplantation for primary sclerosing cholangitis
71. Orthotopic liver transplantation for acute hepatic failure in children
72. OP05 The impact of comorbidities on outcome of patients assessed for liver transplantation, waiting list mortality and post liver transplantation survival using the Charlson comorbidity index
73. P71 A model to improve performance of current category 9 UK listing criteria: early liver graft dysfunction. A single centre cohort
74. 910 EXPANSION OF HEPATIC MACROPHAGES IN ACETAMINOPHEN-INDUCED ACUTE LIVER FAILURE: WHERE DO THEY COME FROM AND WHAT IS THEIR ROLE?
75. 34 LIVER TRANSPLANTATION AFTER CARDIAC DEATH DONATION: SINGLE-CENTRE LONG-TERM RESULTS
76. Gangrene of the anterior abdominal wall after orthotopic liver transplantation: invasive cutaneous candidiasis
77. Fertility after correction of bilateral undescended testes at the age of 23 years
78. Split liver transplantation in paediatric patients - the king's college experience
79. LIVER TRANSPLANTATION USING DONATION AFTER CARDIAC DEATH DONORS: SINGLE-CENTRE LONG-TERM OUTCOME
80. THE ROLE OF LIVER INTERLEUKIN-17-PRODUCING GAMMA/DELTA T CELLS DURING HEPATIC REPERFUSION
81. LONG TERM OUTCOME OF EX SITU RIGHT LOBE SPLIT GRAFTS IN LIVER TRANSPLANTATION
82. PTU-070 Liver failure in association with hepatic amyloidosis and the role of liver transplantation: the King's College Hospital Experience
83. Liver transplantation for fulminant liver failure in children
84. Focal nodular hyperplasia of the liver: a link with sickle cell disease?
85. Selective arterial embolisation for hepatic trauma
86. Congenital Hepatic Arterioportal Fistula
87. HEREDITARY FIBRINOGEN A A ALPHA-CHAIN AMYLOIDOSIS; PHENOTYPIC CHARACTERIZATION AND THE ROLE OF LIVER TRANSPLANTATION
88. OUTCOME OF NON-HEART BEATING DONOR (NHBD) LIVERS IN PAEDIATRIC RECIPIENTS
89. 205 HIGH FREQUENCY OF ANTI-CARDIOLIPIN AND ANTIBETA2 - GLYCOPROTEIN-I POSITIVITY IN PAEDIATRIC LIVER TRANSPLANT RECIPIENTS DEVELOPING VASCULAR COMPLICATIONS
90. Inverted papilloma of the penile urethra
91. Vasa aplasia and cystic fibrosis
92. Body packing--a case report and review of the literature
93. OUTCOME OF HEPATOPULMONARY SYNDROME IN CHILDREN
94. 136 Artificial neural network is superior to meld in predicting mortality of patients with end-stage liver disease
95. Split liver transplantation: A way forward?
96. Auxiliary liver transplantation for metabolic diseases
97. ISCHAEMIC PRECONDITIONING TO CADAVER DONOR LIVERS PROTECTS ALLOGRAFTS AND REDUCES INFLAMMATORY CHANGES AFTER REPERFUSION
98. NON-HEART BEATING VERSUS CADAVERIC LIVER TRANSPLANTATION: DIFFERENCES IN INFLAMMATORY MARKERS FOLLOWING REPERFUSION
99. LIVER TRANSPLANTATION FROM CONTROLLED NON-HEART BEATING DONORS
100. P0237* HEPATOCYTE TRANSPLANTATION: THE ROLE OF THE PAEDIATRIC TRANSPLANT COORDINATOR
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.